News
Masonic Cancer Center announces new Data Sciences leadership
The Masonic Cancer Center (MCC), University of Minnesota is pleased to announce the appointment of J. Sunil Rao, PhD, and Schelomo Marmor, PhD, MPH, as co-associate directors of Data Sciences. Justin Hwang, PhD, has also been named…
Masonic Cancer Center announces new leadership for cancer research training and education
The Masonic Cancer Center (MCC), University of Minnesota is pleased to announce new leadership appointments in Cancer Research Training and Education Coordination (CRTEC). Martin Felices, PhD, was named associate director of CRTEC in April…
Masonic Cancer Center welcomes Scott Dehm as co-leader of the Genomics, Cell States, and Signaling Program
The Masonic Cancer Center, University of Minnesota is pleased to announce that Scott Dehm, PhD, was named co-leader of the Genomics, Cell States, and Signaling (GCSS) research program in April 2026. Dehm joins R.
Masonic Cancer Center announces inaugural Illuminate Gala to advance cancer research through philanthropy
The Masonic Cancer Center (MCC), University of Minnesota has announced its inaugural Illuminate Gala, a fundraising event dedicated to advancing cancer research through philanthropic investment and partnership.Taking place on September 24…
Masonic Cancer Center welcomes new leadership in the Transplant, Cellular and Experimental Therapeutics Program
The Masonic Cancer Center (MCC), University of Minnesota is excited to announce new leadership appointments within the Transplant, Cellular and Experimental Therapeutics (TCET) Program. Branden Moriarity, PhD, and Nick Zorko, MD…
Masonic Cancer Center announces spring 2026 internal grant awardees
The Masonic Cancer Center, University of Minnesota recently announced the awarding of $270,000 in pilot grants through its Spring 2026 Internal Grant Program. Support for these grants is made available by the center through a variety of…
Investigational viral therapy for pancreatic cancer receives international attention
Research led by Masonic Cancer Center investigator Masato Yamamoto, MD, has received international attention following coverage in New Scientist highlighting an early-phase clinical trial of an engineered oncolytic…
Researchers create programmable immune cells for next-generation cancer therapy
Researchers at the Masonic Cancer Center, University of Minnesota, including Martin Felices, PhD, Jeffrey S.
Lung cancer screening rates rise nationwide, including in Minnesota
A new national report published in JAMA Internal Medicine found that lung cancer screening participation increased between 2022 and 2024, with encouraging gains seen across many populations and states. Among racial and ethnic groups,…
Welcoming Denise Windenburg as Director of the Minnesota Cancer Clinical Trials Network
The Minnesota Cancer Clinical Trials Network (MNCCTN) is pleased to welcome Denise Windenburg, MHA, as its Director of Network Operations.Denise brings more than 25 years of experience in clinical research operations, with a career…